Dyne Therapeutics, Inc. (DYN)
15.92
-0.62
(-3.75%)
USD |
NASDAQ |
May 19, 16:00
16.00
+0.08
(+0.50%)
After-Hours: 07:51
Dyne Therapeutics Total Liabilities (Quarterly) : 214.90M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
| Biogen, Inc. | 10.83B |
| Insmed, Inc. | 1.371B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.080B |
| Shareholders Equity (Quarterly) | 865.06M |
| Debt to Equity Ratio | 0.2022 |
| Current Ratio | 19.92 |
| Net Debt Paydown Yield | -1.01% |